Researchers in Cancer and Haematology
Hans-Olov Adami, Cancer epidemiology
Olof Akre, Urology
Sonia Andersson, Gynaecological cancer
Elias Arnér, Selenoproteins
Marie Arsenian Henriksson, MYC genes
Peter Aspelin, Diagnostic radiology
Jiri Bártek, Cancer Biology
Dzevad Belkic, Mathematical radiation physics
Jonas Bergh, Breast cancer
Christer Betsholtz, Vascular biology
Mikael Björnstedt, Selenoproteins
Klas Blomgren, childhood cancer and the developing brain
Lennart Blomqvist, Medical Radiology specialising in Oncology
Anders Brahme, Medical radiation physics
Yvonne Brandberg, Care sciences with focus on oncology
Richard Rosenquist Brandell, Clinical Genetics
Yihai Cao, Mechanisms behind pathological angiogenesis
Tina Dalianis, Tumour virology
Lars Egevad, Urological cancer
Stefan Einhorn, Molecular oncology
Karin Ekström Smedby, Haematology-Oncology and Clinical Epidemiology
Lennart Eriksson, Prevention of liver cancer in patients with chronic liver diseases
Ingemar Ernberg, Tumour biology
Bengt Fadeel, Cell death and cell clearance
Marianne Farnebo, WRAP53
Óscar Fernández-Capetillo, Cancer Therapy
Teresa Frisan, Characterization of the carcinogenic properties of bacterial genotoxins
Jan Frisell, Breast cancer surgery
Susanne Gabrielsson, Immunology and exosomes
Leonard Girnita, Molecular function and targeting of beta-arrestins in cancer
Roland Grafström, Experimental cancer research
Per Hall, Radiation epidemiology and breast cancer
Johan Hansson, Malignant melanoma
Moustapha Hassan, Experimental haematology
Thomas Helleday, Synthetic lethality
Eva Hellström-Lindberg, Myelodysplastic syndrome
Ola Hermanson, Neuroscience and Childhood Cancer
Torbjörn Holm, Colorectal surgery
Arne Holmgren, Thioredoxin and glutaredoxin systems
Lars Holmgren, Tumour biology
Rolf Hultcrantz, Metabolic and inflammatory diseases of the liver
Keith Humphreys, biostatistics in breast cancer epidemiology
Johan Högberg, Toxicology
Magnus Ingelman-Sundberg, Pharmacogenetics
Hans Jacobsson, Nucleo medicine
Randall S. Johnson, Molecular biology and oxygen physiology
Bertrand Joseph, Apoptosis
Rolf Kiessling, Immune and gene therapy
Eva Klein, Tumour biology
Per Kogner, Neuroblastoma
Svetlana Lagercrantz, Medical genetics
Jesper Lagergren, Cancer of the oesophagus and stomach
Pernilla Lagergren, Surgical care sciences
Sonia Lain, Molecular tumour biology
Sir David Lane, Tumour Suppressor Biology, p53
Catharina Larsson, Medical genetics
Jörgen Larsson, Surgery
Lars-Gunnar Larsson, MYC genes
Ola Larsson, Molecular biology
Olle Larsson, IGF-1R and its role in malignant cell growth
Sören Lehmann, Acute myeloid leukemia
Janne Lehtiö, Cancer proteomics to improve therapy
Rolf Lewensohn, Molecular radiation oncology
Stig Linder, Molecular Cancer Pharmacology
Per Ljungman, Viral infections in allogeneic stem cell transplant patients
Weng-Onn Lui, Medical genetics
Karl-Johan Malmberg, Optimizing NK cell therapy for hematological malignancies
Mats Marshall Heyman, Childhood cancer epidemiology
Anna Martling, Colorectal surgery
Maria Masucci, Molecular mechanisms of viral oncogenesis
Håkan Mellstedt, Cancer vaccine research
Stephan Mielke, Haematology and Cell Therapy
Ralf Morgenstern, Biochemical toxicology
Hareth Nahi, Multiple myeloma
Magnus Nilsson, Surgery
Monica Nistér, Brain tumour models
Magnus Nordenskjöld, Clinical genetics
Rolf Ohlsson, Genomic integrity
Sten Orrenius, Molecular mechanisms of cell death and implication in disease
Jan Palmblad, Inflammation and haematology research
Theocharis Panaretakis, Exosome-based biomarkers and novel cancer therapies
Manuel Patarroyo, Adhesion molecules in inflammation and cancer
Teresa Pereira, Regulation of HIF-1 alpha function
Johan Permert, Pancreatic cancer and diabetes
Agneta Rannug, Molecular work environment toxicology
Ulrik Ringborg, Oncology
Olle Ringdén, Allogeneic hematopoietic stem cell transplantation
Charlotte Rolny, Tumour immunology
Kerstin Sandelin, Breast surgery
Birgitta Sander, Molecular pathogenesis of malignant lymphoma
Susanne Schlisio, Cancer biology
Galina Selivanova, p53
Gunnar Steineck, Clinical cancer epidemiology
Sharon Stone-Elander, Cognitive neurophysiology - medical radiochemistry
Peter Strang, Palliative oncology
Anders Sundin, Diagnostic radiology
Laszlo Szekely, Haematological malignant diseases
Margaret Sällberg Chen, Clinical oral immunology and cancer
Jussi Taipale, Medical system biology
Rune Toftgård, Hedgehog signalling in embryonic development and carcinogenesis
Carl-Magnus Wahlgren, Trauma surgery and the blood's ability to coagulate
Margareta Wilhelm, Tumor microenvironment and cancer models
Klas Wiman, p53, Wig-1 and PRIMA-1/APR-246
Jan Zedenius, Surgery specialising in Endocrine Surgery
Anders Zetterberg, Tumour cytology
Boris Zhivotovsky, Molecular mechanisms of cell death and implication in disease
Arne Östman, Tumour stroma and protein tyrosine phosphatases